SynthesisJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026
Efficacy and safety of left atrial appendage occlusion for atrial fibrillation in patients with a history of prior intracranial hemorrhage: a systematic review and meta-analysis of observational studies.
Synthesis in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeft atrial appendage occlusion (LAAO) is emerging as alternative to anticoagulation in patients with nonvalvular atrial fibrillation (AF) to reduce ischemic stroke risk, particularly in those at high bleeding risk.
objectiveAssess LAAO efficacy and safety in patients with prior intracranial hemorrhage (ICH).
methodsSystematic review was performed using PubMed, Embase, and Cochrane Central Register of Controlled Trials. Observational studies reporting outcomes of percutaneous LAAO for AF thromboembolic stroke prophylaxis in patients with prior ICH were included. Classic meta-analysis with risk ratios (RR) for outcomes with control groups and proportions for outcomes without controls were conducted.
resultsA total of 19 observational studies (13 retrospective and 6 prospective) involving 1671 patients met the inclusion criteria. The mean CHA₂DS₂-VASc score was 4.59 ± 0.46, and the mean HAS-BLED score was 3.66 ± 0.56. The mean follow-up duration was 19.1 ± 10.2 months, with follow-up ranging from 6 months to 3.7 years. LAAO was successfully implanted in 99.3% of patients. Periprocedural complications included ICH (0.4%), ischemic stroke (0.3%), pericardial effusion/cardiac tamponade (1.3%), device embolization (0.5%), and device-related thrombosis (0.1%). During follow-up, the incidence of ICH was 1.9%, ischemic stroke/TIA 2.9%, device-related thrombosis 1.4%, and all-cause mortality 3.3%. Using the CHA₂DS₂-VASc score, LAAO significantly reduced ischemic stroke risk (RR = 0.28, 95% CI 0.21-0.39). Similarly, using the HAS-BLED score, bleeding events were reduced (RR = 0.61, 95% CI 0.44-0.84).
conclusionLAAO is effective and relatively safe treatment for reducing ischemic stroke risk in nonvalvular AF patients with history of ICH.
Indexed as
Identifiers
41026441What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.